NCT05760521

Brief Summary

The overall goal of this one-year study is to test a comprehensive protocol for Alzheimer's Disease and Related Dementias (ADRD) diagnosis and care management that can be used as a model for rural communities, which experience low rates of dementia diagnosis and treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
336

participants targeted

Target at P75+ for not_applicable alzheimer-disease

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 24, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 8, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

October 6, 2023

Status Verified

October 1, 2023

Enrollment Period

1.4 years

First QC Date

January 24, 2023

Last Update Submit

October 4, 2023

Conditions

Keywords

RuralMulticulturalEarly DetectionMultidisciplinary

Outcome Measures

Primary Outcomes (4)

  • Change in rates of new dementia diagnosis and treatment

    The intervention and control groups will be compared on rates of dementia diagnosis and treatment at four different time points; baseline and post-intervention.

    at baseline, 3 months, 6 months, and 12 months post-intervention

  • Change in rates of referrals to Area Support Services

    The intervention and control groups will be compared on rates of referrals to support service at four different time points; baseline and post-intervention.

    baseline, 3 months, 6 months, and 12 months post-intervention

  • Change in AD knowledge

    Alzheimer's Disease Knowledge Scale (ADKS) will be collected from participants in the community educational intervention before (week 0) and immediately after the intervention (week 6). Scores on the ADKS range from 0 to 13, with higher scores indicating greater knowledge

    : 6 weeks

  • Change in AD literacy treatment plan.

    Dementia Literacy Assessment (DELA) will be administered as part of the community educational intervention before (week 0) and immediately after the intervention (week 6). DELA consists of 25 items scored 0=incorrect/1=correct. Total DELA score ranges from 0 to 25 with a higher score being indicative of greater dementia literacy.

    6 weeks

Secondary Outcomes (5)

  • Change in rates of preventable admission related to ADRD to the local hospital

    at baseline, 3 months, and 6 months post-intervention

  • Change in provider knowledge related to ADRD

    at baseline, 3 months, and 6 months post-intervention

  • Change in provider confidence in establishing an ADRD diagnosis and treatment plan

    at baseline, 3 months, and 6 months post-intervention

  • Change in caregiver burden

    at baseline, 3 months, and 6 months post-intervention

  • Change in caregiver self-efficacy

    at baseline, 3 months, and 6 months post-intervention

Study Arms (2)

Arm A: Provider Educational Intervention

EXPERIMENTAL

Providers receiving education/support from neurology teams, Adult Gerontological Nurse Practitioner (AGNP) assessments/recommendations, and training of office staff regarding ADRD and community resources support for patients/caregivers.

Other: Provider Educational Intervention

Arm B: Provider Control

NO INTERVENTION

Providers receiving AGNP assessments/recommendations only.

Interventions

Following the informed consent (10 min) and sociodemographic survey (5 minutes), the providers in Arm A will be offered education of two days, six hours each day, with support and follow-up. They will also be asked to complete brief knowledge and confidence surveys pre-post-intervention (30 minutes total).

Arm A: Provider Educational Intervention

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 50 years and older
  • Lives in the Glades Area of Florida
  • Lives in the community/ be non-institutionalized
  • Has no known diagnosis of Alzheimer's Disease and Related Dementias
  • Speaks either English, Spanish, or Creole
  • Has no known plans to move out of the Glades Area in the next 12 months

You may not qualify if:

  • Previous diagnosis of a dementia-related illness
  • Aged under 50 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Palm Beach State College

Belle Glade, Florida, 33430, United States

Location

Florida Atlantic University

Boca Raton, Florida, 33431, United States

Location

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Lisa A Wiese

    Florida Atlantic University, C.E. Lynn College of Nursing

    PRINCIPAL INVESTIGATOR
  • Magdalena I Tolea, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR
  • Joanne Pulido

    Palm Beach State College

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients will not know to which Randomized group that they have been assigned (intervention or control).
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Nursing

Study Record Dates

First Submitted

January 24, 2023

First Posted

March 8, 2023

Study Start

April 1, 2022

Primary Completion

September 1, 2023

Study Completion

September 30, 2023

Last Updated

October 6, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

Data will be de-identified and stored on the PI's university Biomedical Health Research Informatics Core (BHRIC) which is an isolated and independently secured infrastructure managed by the FAU Office of Information technology. The BHRIC Data managed system includes limited access controls, software firewalls, and network-wide virus protection, and daily backups. Data export for analysis is expected to be automated export procedures allowing for seamless download of data into Excel or other widely used statistical packages (SPSS, SAS). Data output tables will be password protected and maintained via password protected university computers. Limited information (informed consents) will be maintained on paper, numerically coded, and secured under lock and key access (further described under the "Informed Consents" section.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
After the data has been analyzed and deidentified. We expect that to be within a year of study closure (March 2024).
Access Criteria
By Request, with approval of Data Management Officer, Research Team, and IRB Officials.

Locations